Cellmax Technologies AB
ABActiveOrg 5566144316Gullfossgatan 1 A, 164 40 KistaWholesale of information and communication equipment· NACE 4650Est. 2001 · 25 years old30 employees
Loading company…
Overview
Cellmax Technologies AB is a Swedish AB based in Kista, operating in the Wholesale of information and communication equipment sector. Incorporated in 2001, the company has 30 employees and reported revenue of SEK 233.0m in its latest annual filing.
Revenue 2025
233M SEK
−6% vs 2024
EBITDA margin
−14.6 %
−4792% vs 2024
Net profit 2025
-37.2M SEK
-714% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
62.7 %
StrongAmong the 40% highest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
2.4×
AverageAround the average of companies in the same industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
-18.9 %
Very weakAmong the 20% lowest rated companies in the industry
20212025
EBITDA — year on year
SEK millionsKey figures
Annual report 2025| Revenue | 233M SEK | -6% |
| EBITDA | -34.1M SEK | -4792% |
| Net profit | -37.2M SEK | -714% |
| Total assets | 196.9M SEK | -11% |
| Equity | 123.5M SEK | -23% |
| Employees | 30 | — |
Company information
Legal name
CELLMAX TECHNOLOGIES AB
Org number
5566144316
Legal form
Aktiebolag
NACE code
Founded
14 August 2001 · 25 years
Share capital
SEK 5,735,055
Employees
30 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva produktionsutveckling och försäljning främst inom telekomsektorn samt äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
(no translation available)
Contact
Address
Gullfossgatan 1 A, 164 40 Kista
Email
naadede.tettey@cellmax.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Cellmax Technologies AB reported revenue of SEK 233.0m, a decrease of 6% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 37.2m, and the EBITDA margin stood at -14.6%.
At the end of 2025, equity financed 62.7% of the balance sheet, and current assets covered short-term debt 2.4 times.
Financials
Revenue
SEK millionsEBITDA
SEK millionsIncome statement
SEK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 233,030 | 247,380 | 196,730 | 357,230 | 347,342 |
| Staff expenses | — | — | — | — | — |
| EBITDA | -34,095 | -697 | 1,111 | 21,892 | 35,943 |
| Depreciation & amort. | -2,601 | -3,275 | -4,500 | -5,456 | -5,117 |
| EBIT | -36,696 | -3,972 | -3,389 | 16,436 | 30,826 |
| Net financials | -513 | -598 | 1,225 | -209 | -187 |
| Profit before tax | -37,209 | -4,569 | -440 | 14,502 | 30,639 |
| Tax | -0 | -0 | -0 | -800 | -4,160 |
| Net profit | -37,209 | -4,569 | -440 | 13,702 | 26,479 |
Balance sheet
SEK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 196,862 | 221,646 | 189,774 | 246,988 | 208,962 |
| Equity | 123,455 | 160,663 | 165,233 | 165,673 | 151,970 |
| Long-term debt | 875 | 880 | 880 | 880 | 880 |
| Short-term debt | 69,770 | 55,098 | 22,156 | 74,615 | 50,917 |
| Total debt | 70,645 | 55,978 | 23,036 | 75,495 | 51,797 |
Financial ratios
5-year trendEBITDA margin
-14.6 %
20212025
Equity ratio
62.7 %
StrongAmong the 40% highest rated companies in the industry
20212025
Return on equity
-30.1 %
Very weakAmong the 20% lowest rated companies in the industry
20212025
Net profit margin
-16.0 %
Very weakAmong the 20% lowest rated companies in the industry
20212025
Asset turnover
1.18×
AverageAround the average of companies in the same industry
20212025
Debt / equity
0.59×
StrongAmong the 40% highest rated companies in the industry
20212025
Sector performance
26 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Operating marginVery weak
Among the 20% lowest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginVery weak
Among the 20% lowest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Very weak
Among the 20% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Very weak
Among the 20% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Very weak
Among the 20% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Very weak
Among the 20% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Capacity ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioAverage
Around the average of companies in the same industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioWeak
Among the 40% lowest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery weak
Among the 20% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityStrong
Among the 40% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalAverage
Around the average of companies in the same industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioWeak
Among the 30% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioStrong
Among the 40% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioStrong
Among the 40% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityStrong
Among the 40% highest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityStrong
Among the 40% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtVery weak
Among the 20% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery weak
Among the 20% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageVery weak
Among the 20% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtWeak
Among the 40% lowest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginVery weak
Among the 20% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverAverage
Around the average of companies in the same industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverStrong
Among the 30% highest rated companies in the industry
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Equity to contributed capitalStrong
Among the 30% highest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityVery weak
Among the 20% lowest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtWeak
Among the 30% lowest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
ND Authorized Recipient of Service | Authorized Recipient of Service | 2022 |
NR Chief Executive Officer | Chief Executive Officer | 2022 |
AO Chief Auditor | Chief Auditor | 2022 |
Former (2)
SJ Chief Auditor | Chief Auditor | 2020 – 2022 |
HA Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
MF Chairman | Chairman | 2020 |
EK Board of Directors | Board of Directors | 2020 |
JN Board of Directors | Board of Directors | 2022 |
Former (2)
HG Board of Directors | Board of Directors | 2020 – 2020 |
PM Board of Directors | Board of Directors | 2020 – 2022 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Related companies
Company hierarchy
Rosenberger Hochfrequentztechnic GmbH100%
Cellmax Technologies AB (this company)Board network connections
Board members of Cellmax Technologies AB also hold positions in 412 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anton Ola Spinnars | Chief Auditor | 208 companiesMany roles |
| Sten Johan Pharmanson | Chief Auditor | 190 companiesMany roles |
| Naa Dede Onigi Tettey | Authorized Recipient of Service | 4 companies |
| Nils Reine Eriksson | Chief Executive Officer | 4 companies |
| Hans Georg Rosenberger | Board of Directors | 3 companies |
| Hammad Abu Iseifan | Chief Executive Officer | 1 company |
| Marc Friedrich Käumle | Chairman | 1 company |
| Josef Nikolaus Rottenaicher | Board of Directors | 1 company |
Frequently asked questions
What is the Org number of Cellmax Technologies AB?
Cellmax Technologies AB is registered with Bolagsverket / SCB under Org 5566144316.
What is the revenue of Cellmax Technologies AB?
Cellmax Technologies AB reported revenue of SEK 233.0m in 2025.
How many employees does Cellmax Technologies AB have?
Cellmax Technologies AB employs 30 people as of the latest annual report.
Who is the CEO of Cellmax Technologies AB?
Nils Reine Eriksson is the CEO of Cellmax Technologies AB, in role since 2022.
Who is the chairman of Cellmax Technologies AB?
Marc Friedrich Käumle chairs the board of Cellmax Technologies AB, in role since 2020.
Where is Cellmax Technologies AB headquartered?
Cellmax Technologies AB's registered address is Gullfossgatan 1 A.